Tiffany D.Lipscomb-Jackson

Partner

Columbus + 1.614.281.3876

Tiffany Lipscomb-Jackson is a seasoned commercial litigator with substantial experience in the petroleum, pharmaceutical, and agricultural industries, with a focus on antitrust and competition issues. She has extensive experience with multijurisdictional and multiparty matters alleging bid-rigging, price-fixing, and illegal monopolization brought by private plaintiffs and state attorneys general. This work includes defending against allegations premised on the alleged misuse of intellectual property rights or the regulatory approval processes to extend market exclusivity for brand name drugs (purported "product hops").

Tiffany has more than a decade of experience defending clients in bet-the-company class action litigation in a wide range of cases, including antitrust, consumer protection, civil RICO, and breach of contract. She recently won dismissal for Chamberlain University in a breach-of-contract class action arising out of COVID-19 and successfully defended the dismissal on appeal to the Sixth Circuit. Other exemplary experience includes obtaining summary judgment for Marathon and excluding Kentucky's sole expert in a Sherman Act Section 1-2 case; obtaining summary judgment for a large client on Lanham Act claims; and representing National Beef in class action litigation involving its cattle procurement practices.

Tiffany has a robust pro bono practice, which includes successfully representing immigrants seeking relief before the United States Immigration Court and federal courts of appeal. She is also a board member for Lawyers Without Borders.

Experience

  • Indivior resolves antitrust and fraud claimsJones Day resolved litigation filed by five insurance companies alleging that Indivior, Inc. had attempted to illegally monopolize the market for its prescription drug Suboxone.
  • Indivior resolves "product hop" allegations in antitrust class actionJones Day resolved multidistrict litigation brought against Indivior, Inc. Indivior manufactures the prescription drug, Suboxone, which is used to treat opioid addiction.
  • Safelite secures complete dismissal of qui tam suitA Jones Day cross-office team achieved a complete dismissal of a California insurance fraud qui tam suit for our client Safelite, the market leader in vehicle glass repair and replacement services.
  • Dr. Reddy's Laboratories successfully resolves antitrust claims alleging "pay-for-delay" pharmaceutical patent settlementJones Day successfully resolved antitrust class action litigation in which plaintiffs alleged that Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. violated antitrust and related laws through the settlement of Hatch-Waxman patent litigation.
  • Indivior obtains Third Circuit affirmation of dismissal of RICO, state law claimsOn December 15, 2022, the United States Court of Appeals for the Third Circuit ruled in favor of Jones Day clients Indivior Inc., Indivior Solutions Inc., and Indivior plc.
  • Chamberlain University obtains Sixth Circuit affirmance dismissing breach of contract lawsuitA Jones Day cross-office team secured a significant appellate victory in the Sixth Circuit for Chamberlain University, a nursing school with campuses in 15 states and a subsidiary of Adtalem Global Education.
  • Eaton sells hydraulics business to DanfossJones Day advised Eaton Corporation as antitrust counsel in the sale of its hydraulics business to Danfoss Power Solutions for US$3.3 billion.
  • PITCO Foods develops program to address COVID-19 spread at workJones Day represents PITCO Foods, Inc., a food supply company based in California, during the COVID-19 crisis to consider and assess appropriate protocols and policies to mitigate the spread of COVID-19 among employees, including a testing program for returning and new workers.
  • Yazaki successfully resolves automaker lawsuit alleging price-fixing and bid riggingJones Day represented Yazaki Corporation and Yazaki North America, Inc. in successfully resolving a civil antitrust lawsuit brought by an automaker following Jones Day's filing of motions for summary judgment and to exclude the plaintiff's sole expert witness.
  • Marathon secures Daubert and summary judgment wins dismissing Kentucky AG's antitrust claimsJones Day secured dismissals on behalf of Marathon Petroleum Corporation ("Marathon Corp."), Marathon Petroleum Company, LP ("MPC LP"), and Speedway LLC ("Speedway," and collectively, "Marathon") in an antitrust suit brought by the Commonwealth of Kentucky seeking more than $173.6 million in damages related to the sale of reformulated gasoline ("RFG") in Louisville and Northern Kentucky (collectively, "NKY").
  • Pro bono client cleared of wrongful conviction and released from Michigan prisonJones Day represented George Clark, a man who was released from a Michigan State prison in April 2020, eighteen years after he was wrongfully convicted of first-degree murder and sentenced to life without parole.
  • Telehealth company expands programming in response to COVID-19 public health crisisJones Day represented a telehealth company in the expansion of their telehealth programming in response to the COVID-19 public health crisis and related health regulatory and contracting matters.
  • Large critical infrastructure employer considers implementing COVID-19 testing program for employeesJones Day represented a large critical infrastructure employer during the COVID-19 crisis to consider and assess appropriate protocols and policies for implementing an employee COVID-19 testing program at its sites. This included counseling on myriad federal, state, and local legal and regulatory frameworks as well as forming appropriate partnerships.
  • Luxury department store chain develops employee programming to mitigate spread of COVID-19 within workplaceJones Day represented a luxury department store chain during the COVID-19 crisis to develop appropriate protocols and policies for implementing an employee temperature screening program, a face covering program, work from home and return to work policies for employees suffering from COVID-19, respiratory illness, or exposure to individuals with COVID-19.
  • Medical equipment company responds to U.S. federal RFI, develops global strategy for responding to requests for specialized medical equipment in response to COVID-19 pandemicJones Day advised a medical equipment company in their response to a U.S. federal RFI for specialized medical equipment in response to the COVID-19 pandemic, in development of a global strategy regarding response to multiple state and country requests for specialized medical equipment, and in related antitrust and regulatory issues.
  • Petitioner in ineffective assistance case obtains unanimous Seventh Circuit panel decision to remand case to Board of Immigration AppealsJones Day successfully represented client R—a 44 year old native and citizen of Mexico who has lived in the United States for more than 25 years—in his petition to the Seventh Circuit Court of Appeals to review the Board of Immigration Appeals' denial of his motion to reopen his appeal asserting ineffective assistance of counsel.
  • Nationwide and Northstar litigate dispute surrounding design-build project for residential wastewater treatment facilityJones Day is representing plaintiffs Nationwide Realty Investors and Northstar Residential Development in litigation arising out of a design-build project for a residential wastewater treatment facility to serve the Northstar Community in Sunbury, Ohio.
  • Yazaki defends against automotive wire harness antitrust class actionsJones Day represents Yazaki North America and Yazaki Corporation in connection with numerous antitrust class action complaints alleging that Yazaki and other auto parts manufacturers violated the Sherman Act by engaging in bid-rigging and price-fixing in sales of automotive wire harnesses and related products.
  • Aventis Pharmaceuticals successfully defends against monopolization claims based on fraud on the Patent Office theoryJones Day resolved class action claims that Aventis Pharmaceuticals, the exclusive licensee of patents covering DDAVP (a treatment for certain water metabolism disorders), knew that the licensor obtained those patents by fraud before the Patent and Trademark Office.
  • Jones Day secures guardianship in highly contested caseJones Day represented an aunt and uncle in seeking guardianship of their three young nieces. 
  • Additional Speaking Engagements

    • June 9, 2020
      Defending Third-Party Covid-19 Claims Alleging Personal Injury Or Exposure To The Virus: Lessons Learned From Prior Crises For Preventing, Preparing For, and Defending Such Claims
    • June 3, 2020
      Return to Workplace: Legal Considerations U.S. Companies Need to Know Post-COVID-19
    • May 13, 2020
      Practical Considerations for Contract Review and Evaluation Amidst COVID-19
    • October 17, 2018
      Jones Day Data Breach Class Actions--an interactive webex covering the rise in data breaches and resulting litigation, what you can do to prepare, and what to do if a breach occurs
    • December 13, 2016
      Trial Evidence for the Ohio Practitioner: Hearsay
    • December 6, 2016
      Avoiding "Oops" Antitrust Litigation: An Antitrust Primer for the Non-Antitrust Attorney
    • April 9, 2014
      Women in eDiscovery: Panel on Cross Border eDiscovery
    • April 25, 2012
      Rule 26(f) Conferences: How to Prepare and What to Discuss, West LegalEdCenter
    • December 2011
      Jones Day's Tiffany Lipscomb-Jackson provides advice and insight to students at her alma mater -- Ohio State University Moritz College of Law